Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
Go back to Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions| ATA, Inc. (NASDAQ: ATAI) | Delayed: 7.21 -0.04 (0.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.25 | 52 Week High | $7.32 | |||
| Open | $7.24 | 52 Week Low | $3.30 | |||
| Day High | $7.26 | P/E | N/A | |||
| Day Low | $7.21 | EPS | $0.00 | |||
| Volume | 3,667,075 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1215.02 -16.92 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1231.94 | 52 Week High | $88.16 | |||
| Open | $1230.65 | 52 Week Low | $67.88 | |||
| Day High | $1238.00 | P/E | 281.25 | |||
| Day Low | $1209.53 | EPS | $4.32 | |||
| Volume | 2,113,465 | |||||
